Search Results
Search results for "roots analysis"
Roots Analysis
Roots Analysis specializes in providing reports offering thorough perspectives on under-researched areas within broader industries, in addition to bespoke consulting services.
Stem Cell Therapy Market Analysis
The stem cell therapy market has gained traction. There are multiple approved products and several companies are advancing their proprietary therapy candidates.
The global (Artificial Intelligence) AI in energy market is projected to reach…
Growing awareness of the impending energy crisis and the need to reduce carbon emissions, have led to the development of AI-based technologies to facilitate optimal power consumption and adoption of energy efficient infrastructure
Cell & Gene Therapy Bioassay Services Market Analysis
Roots Analysis helps companies in the cell and gene therapy bioassay services field compare their capabilities and identify ways to gain a competitive edge.
Contract Regulatory Affairs for Medical Devices Market Analysis
Roots Analysis provides a detailed study on the current landscape of contract service providers focused on regulatory affairs management for medical devices.
Wearable Injectors Market Analysis
Roots Analysis provides market research on evolving dynamics of large volume wearable injectors and challenges of high volume formulations.
USD 1.5 Billion Vaccine Delivery Devices Market by 2030
Roots Analysis claims the novel vaccine delivery devices market is projected to be worth USD 1.5 billion by 2030, growing at a CAGR of 20%.
Collaborative Robots Market to Reach USD 18 Billion by 2030
Roots Analysis claims the global collaborative robots (cobots) market is projected to be worth USD 18 billion by 2030, based on active stakeholder investment.
Breast Implants Market Analysis Report
Market research report from Roots Analysis estimates the overall market size and share of key regional segments in the Breast Implants Market by 2035.
Soft Tissue Sarcoma Market Projected to Reach USD 420 Million by 2030
Roots Analysis projects the Soft Tissue Sarcoma market to exceed USD 420 Million by 2030, with a report focusing on Angiosarcoma, Chondrosarcoma, and Liposarcoma.